The Complainant is a German family-owned pharmaceutical group of companies with roots going back to 1885, when it was founded by Albert Boehringer in Ingelheim am Rhein. Today, the Complainant is one of the world's leading research-driven pharmaceutical companies with about 140 affiliate companies world-wide and over 53,000 employees. The three business areas of Boehringer Ingelheim are human pharmaceuticals, animal health and bio pharmaceuticals. In 2022, net sales of the Boehringer Ingelheim group amounted to about EUR 24.1 billion. JARDIANCE (Empagliflozin) is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes, and also to reduce the risk of cardiovascular death in adults with type 2 diabetes who have a known cardiovascular disease. <\/p>\n
The disputed domain name <jardiance.life> was registered on 21 October 2023 and resolves to a parking page with commercial links; MX records have also been configured. <\/p>", "other_legal_proceedings": "
The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "
The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.<\/p>\n
No administratively compliant Response has been filed. <\/p>", "rights": "
The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trade mark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "
The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "
The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "
The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Gregor Kleinknecht LLM MCIArb" ], "date_of_panel_decision": "2023-12-03 00:00:00", "informal_english_translation": "
The Complainant owns the international trade mark JARDIANCE, registration number 981336, first registered on 3 September 2008 in international class 5. The Complainant’s trade mark registration predates the registration of the disputed domain name.<\/p>\n
The Complainant also owns the domain name <Jardiance.com>, registered on 30 April 2008, which consists of and incorporates the name JARDIANCE and is connected to the Complainant’s official website through which it informs Internet users and customers about its JARDIANCE product. <\/p>", "decision_domains": { "jardiance.life": "TRANSFERRED" }, "panelist": null, "panellists_text": null }